Ford, Hugo E R <br/><br/>
A phase II study of weekly docetaxel in patients with anthracycline pretreated metastatic breast cancer.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  Dec 2006 
 - 809-15 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/s00280-006-0222-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alopecia--chemically induced<br/>Anthracyclines--therapeutic use<br/>Antineoplastic Agents, Phytogenic--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Diarrhea--chemically induced<br/>Docetaxel<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neutropenia--chemically induced<br/>Survival Analysis<br/>Taxoids--administration & dosage<br/>Thrombocytopenia--chemically induced<br/>Treatment Outcome